DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 67 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $677,255 | +105.5% | 55,196 | +100.0% | 0.00% | – |
| Q2 2023 | $329,520 | -10.7% | 27,598 | 0.0% | 0.00% | – |
| Q1 2023 | $368,985 | -63.0% | 27,598 | -40.4% | 0.00% | -100.0% |
| Q4 2022 | $997,065 | +9.7% | 46,332 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $909,000 | +9.7% | 46,332 | -0.0% | 0.00% | 0.0% |
| Q2 2022 | $829,000 | +123.5% | 46,333 | +23.7% | 0.00% | – |
| Q1 2022 | $371,000 | -41.2% | 37,449 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $631,000 | +57.8% | 37,449 | +122.2% | 0.00% | – |
| Q3 2021 | $400,000 | 0.0% | 16,856 | 0.0% | 0.00% | – |
| Q2 2021 | $400,000 | – | 16,856 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |